In order to systematically study the role of FTO in cervical cancer, we searched GSE44001 data and found that FTO was significantly up‐regulated in FIGO stage II cervical cancer patients, compared with stage I (p < 0.05, Figure 1C) [45]. This evidence concerns the gene FTO and cervical carcinoma.